[Federal Register Volume 67, Number 52 (Monday, March 18, 2002)]
[Notices]
[Pages 12049-12050]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-6324]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 13, 2001, 
Mallinckrodt, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 
63147, made application by letter to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
Difenoxin (9168)...........................  I
Morphine-N-oxide (9307)....................  I
Normorphine (9313).........................  I
Norlevorphanol (9634)......................  I
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The firm plans to manufacture the controlled substances as an 
analytical reference standard to be utilized

[[Page 12050]]

internally and for sale to other companies.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Registered Representative 
(CCR), and must be filed no later than May 17, 2002.

    Dated: December 28, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-6324 Filed 3-15-02; 8:45 am]
BILLING CODE 4410-09-M